UJCR; 2023, Vol. 3, Issue 3

Maqola mavzusi

Патогенез, клинические проявления инсультов, лечение (29-32)

Mualliflar

Сраилова К.Б., Раимкулов Б.Н., Нургужаев Е.С., Раимкулова Х.Б.

Muassasa

Казахский Национальный медицинский университет имени С. Д. Асфендиярова

Annotatsiya

В данной статье представлен краткий патогенез возникновения инсультов, клинические проявления и лечение инсультов. Отмечены наиболее важные факторы развития инсультов.

Kalit so'zlar

патогенез инсультов, клинические проявления церебральных инсультов, методы лечения инсультов, ишемический инсульт.

Adabiyotlar

1. Gusev EI, Skvortsova VI, Stakhovskaya JB. The problem of stroke in the Russian Federation: the time of active joint actions. J Neurol Psychiatry. 2017;8:4-10. 2. Gutmann B, Hutter-Paier B, Skofitsch G, et al. In vitro models of brain ischemia: the peptidergic drug cerebrolysin protects cultured chick cortical neurons from cell death. Neurotox Res. 2012;4:59-65. 3. Vereshchagin NV, Varakin VYa. Prevention of acute disorders of cerebral circulation: theory and reality. Zhurn Nevrol Psikhiatr. 1996;5:4-9. 4. Parfenov AA, Skoromets NN, Yakhno NN. Circulatory disorders in the brain and spinal cord. In: Yakhno NN, Shtulman DR, eds. Diseases of the Nervous System. Vol. 1. Moscow: Medicine; 2003. p. 231-302. 5. Grady BO. Development and implementation of a comprehensive system of care for stroke. J Neurol Psychiatry. 2007;Special Issue:133-136. 6. Skvortsova VI, Chazova IE, Stakhovskaya LV. Secondary prevention of stroke. Moscow: Meditsina; 2002. p. 188. 7. Zhulev NM. Cerebrovascular diseases. Prevention and treatment of stroke. St. Petersburg: Nevsky Dialect; 2003. p. 384. 8. Suslina ZA, Maksimova MYu. Private neurology. Moscow: Praktika; 2012. p. 272. 9. Belichenko OI, Dadvani SA, Abramova NN, Ternovoy SK. MRI in the diagnosis of cerebrovascular diseases. Moscow: Vidar-M; 1998. p. 112. 10. Vibers D, Feigin V, Brown R. A guide to cerebrovascular disease. Moscow: 1999. p. 672. 11. Dubuc V., Moore D.F., Gioia L.C. [et al.] Prevalence of Fabry Disease in Young Patients with Cryptogenic Ischemic Stroke // Journal of Stroke. 2013;22(8):1288-1292. 12. Zenonea T., Chanb V. Young woman with recurrent ischemic strokes diagnosed as Fabry disease: Lessons learned from a case report // Clinical Neurology and Neurosurgery. 2011;113(7):586-588. 13. Chirva N.N. Individual prediction of the development of recurrent stroke and its secondary prevention [dissertation]. Moscow; 2005. p. 22. 14. Gusev E.I. The problem of stroke in Russia // Journal of Neurology and Psychiatry. S.S.Korsakov. Special issue. 2003;3-5. 15. Skoromets A.A., Skoromets A.P., Skoromets T.A. Nervous diseases. Moscow: MEDpress-inform; 2017. p. 552. 16. Skvortsova V.I., Efremova N.V., Shamalov N.A. et al. Cerebral ischemia and neuroprotection // Quality of life. Medicine. 2016;12(16):35-42. 17. Suslina Z.A. Vascular pathology of the brain: results and prospects // Annals of Clinical and Experimental Neurology. 2017;1(1):10-16. 18. Skvortsova V.I., Chazova I.E., Stakhovskaya JI.B. et al. Primary prevention of stroke // Quality of life. Medicine. 2016;2(13):72-77. 19. Suslina Z.A., Varakin Yu.Ya. Epidemiological aspects of the study of stroke. Time to sum up // Annals of Clinical and Experimental Neurology. 2017;1(2):22-28. 20. Vereshchagin N.V., Suslina Z.A., Piradov M.A., Geraskina L.A., Yakhno N.N., Valenkova V.A. Principles of diagnosis and treatment of patients with acute cerebrovascular accident // Methodological recommendations of the Research Institute of Neurology of the Russian Academy of Medical Sciences. Moscow; 2000. p. 44. 21. Ministry of Health and Social Development of the Republic of Kazakhstan. Clinical protocols. July 13, 2016. Protocol No. 7. 22. Ministry of Health and Social Development of the Republic of Kazakhstan. Clinical protocols. December 27, 2016. Protocol No. 18. 23. European Stroke Organization (ESO) Executive Committee, ESO Authors Committee. Recommendations for the management of patients with ischemic stroke and transient ischemic attacks. 2008. 24. Skvortsova VI, editor. Acute stroke. Moscow: GEOTAR-Media; 2009. ASA scientific statement. Guidelines for the management of patients with ischemic stroke. Stroke. 2005;36:916-923. 25. European Stroke Initiative. Recommendations for stroke management: update 2003. Cerebrovasc Dis. 2003;16:311-337. 26. Sacco RL, Adams R, Albers GW, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke. 2006;37:577-617. 27. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischemic attack. Lancet. 2007;369:283-292. 28. Johnston SC, Nguyen-Huyen MN, Schwarz ME, et al. National Stroke Association Guidelines for the management of transient ischemic attacks. Ann Neurol. 2006;60(3):301-313. 29. Shah KH, Edlow JA. Transient ischemic attack: review for the emergency physician. Ann Emerg Med. 2004;43:592-604. 30. Yavorskaya VA, Flomin YV. Transient ischemic attacks: more than «microstrokes». J Emerg Med. 2008;6(19):29-35. 31. Pokrovsky AV, Beloyartsev DF. Significance of carotid endarterectomy in the prevention of ischemic brain damage. Journal of Neurology and Psychiatry named after S.S. Korsakov. Special Editions. 2015;115(9-2):4-14. 32. Norvils SN, Tsareva IV, Staritsyn AN, et al. Management of patients with neurogenic dysphagia in the acute period of stroke (an interdisciplinary approach). Consilium Medicum. 2015;17(9):50-54. DOI:10.26442/2075-1753_2015.9.50-54. 33. Kadykov AS, Shakhparonova NV. Vascular diseases of the brain: reference book. Moscow: Miklós; 2010. p. 200. 34. Ivanova GE, Polyaev BA, Hoffman YaB. Features of impaired motor function in patients with cerebral stroke. Journal of Neurology and Psychiatry. S.S. Korsakova. 2003;9:166. 35. Lutskiy MA, Uvarova MV, Savinykh VP, Bykova VA. Diagnosis of occipital lobe epilepsy. Epilepsy and paroxysmal conditions. 2017;9(3):18-21. (In Russian) 36. Belova LA. Stroke: treatment at the prehospital stage and in a specialized department. Journal: Selected Issues of Clinical Medicine in General Practice. No. 7 (147); 17-22. 37. Stang A, Hense HW, Jöckel KH, et al. Is it always unethical to use a placebo in a clinical trial? PLoS Med. 2005;2(3):e72. 38. World Stroke Campaign. [Online] Available: http://www.worldstrokecampaign.org/images/global_stroke_bill_of_ rights/English_GlobalBORights_web.pdf (accessed March 16, 2018) 2018. 39. Johnson W, et al. Stroke: a global response is needed. Bulletin of the World Health Organization. 2016;94(9):634. 40. Action Plan for Stroke in Europe 2018-2030. European Stroke Journal. 2018;3(4):309-336! European Stroke Organisation. 41. Damrow J, Gaarder K, Chopra S. Global Stroke Bill of Rights. International Journal of Stroke. December 2014;9(8). DOI:10.1111/ijs.12399. 42. World Stroke Campaign. English_GlobalBO-Rights_web.pdf (accessed March 16, 2018) 2018.